Multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ponesimod, an S1P1 receptor modulator: favorable impact of dose up-titration. - CRS. Experts. Early Phase.

Multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ponesimod, an S1P1 receptor modulator: favorable impact of dose up-titration.

Science

ShareTwitter FacebookXingLinkedin

First published in The Journal of Clinical Pharmacology on 2014 Feb.
J Clin Pharmacol. 2014 Feb;54(2):179-88. doi: 10.1002/jcph.244. Epub 2014 Jan 9

Authors: Brossard P, Scherz M, Halabi A, Maatouk H, Krause A, Dingemanse J.

Read more

Download full article as Pdf file:

REACHING OUT IS EASY AND FAST – LET’S TALK

Prof. Dr. Thomas Forst

Chairman of the Executive Board

LET’S TALK SCIENCE

+49 621 150 45 – 0

Martin Mulder

Senior Vice President Corporate & Business Development

LET’S TALK BUSINESS

+49 621 150 45 – 0

immunomodulator pharmacodynamics pharmacokinetics safety tolerability

You May Also Like

Science 16. November 2023

Pharmacokinetics, Safety, and Tolerability of the Novel Tetrameric, High-Relaxivity, Macrocyclic Gadolinium-Based Contrast Agent Gadoquatrane in Healthy Adults

Science 16. November 2023

Effect of nivasorexant (ACT-539313), a selective orexin-1-receptor antagonist, on multiple cytochrome P450 probe substrates in vitro and in vivo using a cocktail approach in healthy subjects

Science 25. Mai 2023

CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes